Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis von Talpaz, Moshe, Kiladjian, Jean-Jacques

Volltext

Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies von Kiladjian, Jean-Jacques, Cassinat, Bruno

Volltext

Thromboembolic events in polycythemia vera von Griesshammer, Martin, Kiladjian, Jean-Jacques, Besses, Carlos

Volltext

Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure von Harrison, Claire N., Schaap, Nicolaas, Vannucchi, Alessandro M., Kiladjian, Jean‐Jacques, Jourdan, Eric, Silver, Richard T., Schouten, Harry C., Passamonti, Francesco, Zweegman, Sonja, Talpaz, Moshe, Verstovsek, Srdan, Rose, Shelonitda, Shen, Juan, Berry, Tymara, Brownstein, Carrie, Mesa, Ruben A.

Volltext

Myelofibrosis: Current unmet needs, emerging treatments, and future perspectives von Harrison, Claire N., Kiladjian, Jean‐Jacques, Koschmieder, Steffen, Passamonti, Francesco

Volltext

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis von Harrison, Claire, Kiladjian, Jean-Jacques, Al-Ali, Haifa Kathrin, Gisslinger, Heinz, Waltzman, Roger, Stalbovskaya, Viktoriya, McQuitty, Mari, Hunter, Deborah S, Levy, Richard, Knoops, Laurent, Cervantes, Francisco, Vannucchi, Alessandro M, Barbui, Tiziano, Barosi, Giovanni

Volltext

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet von Barbui, Tiziano, Tefferi, Ayalew, Vannucchi, Alessandro M., Passamonti, Francesco, Silver, Richard T., Hoffman, Ronald, Verstovsek, Srdan, Mesa, Ruben, Kiladjian, Jean-Jacques, Hehlmann, Rȕdiger, Reiter, Andreas, Cervantes, Francisco, Harrison, Claire, Mc Mullin, Mary Frances, Hasselbalch, Hans Carl, Koschmieder, Steffen, Marchetti, Monia, Bacigalupo, Andrea, Finazzi, Guido, Kroeger, Nicolaus, Griesshammer, Martin, Birgegard, Gunnar, Barosi, Giovanni

Volltext

Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature von Goulart, Hannah, Masarova, Lucia, Mesa, Ruben, Harrison, Claire, Kiladjian, Jean-Jacques, Pemmaraju, Naveen

Volltext

From leeches to interferon: should cytoreduction be prescribed for all patients with polycythemia vera? von Kiladjian, Jean-Jacques, Barbui, Tiziano

Volltext

Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase‐2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts von Harrison, Claire N., Schaap, Nicolaas, Vannucchi, Alessandro M., Kiladjian, Jean‐Jacques, Passamonti, Francesco, Zweegman, Sonja, Talpaz, Moshe, Verstovsek, Srdan, Rose, Shelonitda, Zhang, Jun, Sy, Oumar, Mesa, Ruben A.

Volltext

Early intervention in myelofibrosis and impact on outcomes: A pooled analysis of the COMFORT‐I and COMFORT‐II studies von Verstovsek, Srdan, Kiladjian, Jean‐Jacques, Vannucchi, Alessandro M., Mesa, Ruben A., Squier, Peg, Hamer‐Maansson, J. E., Harrison, Claire

Volltext

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b von Kiladjian, Jean-Jacques, Klade, Christoph, Georgiev, Pencho, Krochmalczyk, Dorota, Gercheva-Kyuchukova, Liana, Egyed, Miklos, Dulicek, Petr, Illes, Arpad, Pylypenko, Halyna, Sivcheva, Lylia, Mayer, Jiří, Yablokova, Vera, Krejcy, Kurt, Empson, Victoria, Hasselbalch, Hans C., Kralovics, Robert, Gisslinger, Heinz

Volltext

The renaissance of interferon therapy for the treatment of myeloid malignancies von Kiladjian, Jean-Jacques, Mesa, Ruben A., Hoffman, Ronald

Volltext

Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses von Verstovsek, Srdan, Gotlib, Jason, Mesa, Ruben A, Vannucchi, Alessandro M, Kiladjian, Jean-Jacques, Cervantes, Francisco, Harrison, Claire N, Paquette, Ronald, Sun, William, Naim, Ahmad, Langmuir, Peter, Dong, Tuochuan, Gopalakrishna, Prashanth, Gupta, Vikas

Volltext

Interferon Alfa Therapy in CALR-Mutated Essential Thrombocythemia von Cassinat, Bruno, Verger, Emmanuelle, Kiladjian, Jean-Jacques

Volltext

Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis von Mascarenhas, John, Komrokji, Rami S., Palandri, Francesca, Martino, Bruno, Niederwieser, Dietger, Reiter, Andreas, Scott, Bart L., Baer, Maria R., Hoffman, Ronald, Odenike, Olatoyosi, Vannucchi, Alessandro M., Bussolari, Jacqueline, Zhu, Eugene, Rose, Esther, Sherman, Laurie, Dougherty, Souria, Sun, Libo, Huang, Fei, Wan, Ying, Feller, Faye M., Rizo, Aleksandra, Kiladjian, Jean-Jacques

Volltext

Treatment of Polycythemia Vera With Hydroxyurea and Pipobroman: Final Results of a Randomized Trial Initiated in 1980 von KILADJIAN, Jean-Jacques, CHEVRET, Sylvie, DOSQUET, Christine, CHOMIENNE, Christine, RAIN, Jean-Didier

Volltext

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis von Vannucchi, Alessandro M, Kantarjian, Hagop M, Kiladjian, Jean-Jacques, Gotlib, Jason, Cervantes, Francisco, Mesa, Ruben A, Sarlis, Nicholas J, Peng, Wei, Sandor, Victor, Gopalakrishna, Prashanth, Hmissi, Abdel, Stalbovskaya, Viktoriya, Gupta, Vikas, Harrison, Claire, Verstovsek, Srdan

Volltext

Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review von Ianotto, Jean-Christophe, Curto-Garcia, Natalia, Lauermanova, Marie, Radia, Deepti, Kiladjian, Jean-Jacques, Harrison, Claire N

Volltext

Clonal evolution in hereditary thrombocytosis with MPL T487A mutation von Vasseur, Loic, Favier, Remi, Kim, Rathana, Rabian, Florence, Cabannes‐Hamy, Aurelie, Cassinat, Bruno, Maslah, Nabih, Vasquez, Nadia, Clappier, Emmanuelle, Kiladjian, Jean‐Jacques, Boissel, Nicolas

Volltext